• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P50 通过反映肺外器官功能障碍暗示了儿科急性呼吸窘迫综合征的不良临床结局。

P50 implies adverse clinical outcomes in pediatric acute respiratory distress syndrome by reflecting extrapulmonary organ dysfunction.

机构信息

Department of Pediatrics, Severance Children's Hospital, Institute of Allergy, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.

Department of Pediatrics, Kyung Hee University College of Medicine, Seoul, Republic of Korea.

出版信息

Sci Rep. 2022 Aug 11;12(1):13666. doi: 10.1038/s41598-022-18038-6.

DOI:10.1038/s41598-022-18038-6
PMID:35953629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9372160/
Abstract

Hypoxemia and multiple organ dysfunction are significant contributors to mortality in patients with pediatric acute respiratory distress syndrome (PARDS). P50, the oxygen tension at which hemoglobin is 50% saturated, is a measure of hemoglobin-oxygen affinity, and its alteration might have implications for tissue hypoxia and organ dysfunction. The purpose of this single-center, retrospective study was to evaluate P50 levels in PARDS and to determine the association between P50 and clinical outcomes. The study included 212 children diagnosed with PARDS according to the Pediatric Acute Lung Injury Consensus Conference definition who required invasive mechanical ventilation and had arterial blood gas results of hemoglobin oxygen saturation < 97% at the time of diagnosis. P50 levels were calculated using Doyle's method, and organ dysfunction was assessed using the Pediatric Logistic Organ Dysfunction-2 score. Most patients exhibited more than one dysfunctional extrapulmonary organ at PARDS onset. P50 increased with increasing PARDS severity (mild (26.6 [24.9-29.6]), moderate (26.8 [25.0-29.5]), and severe PARDS (29.1 [26.1-32.4] mmHg; P = 0.025). Moreover, P50 demonstrated a significant positive association with extrapulmonary organ dysfunction score (β = 0.158, P = 0.007) and risk of mortality (adjusted hazard ratio, 1.056; 95% confidence interval, 1.015-1.098; P = 0.007), irrespective of initial PARDS severity. The relationship between P50 and mortality was largely mediated by extrapulmonary organ dysfunction. A high P50 value at the time of PARDS diagnosis may be associated with mortality via dysfunctional extrapulmonary organs. Future studies should consider P50 as a potential candidate index for risk stratification of PARDS patients.

摘要

低氧血症和多器官功能障碍是小儿急性呼吸窘迫综合征(PARDS)患者死亡的重要原因。P50 是血红蛋白饱和度为 50%时的氧分压,是血红蛋白-氧亲和力的度量,其改变可能对组织缺氧和器官功能障碍有影响。本单中心回顾性研究的目的是评估 PARDS 患者的 P50 水平,并确定 P50 与临床结局之间的关系。该研究纳入了 212 名根据小儿急性肺损伤共识会议定义诊断为 PARDS 的儿童,这些儿童需要有创机械通气,并且在诊断时动脉血气血红蛋白氧饱和度 < 97%。P50 水平使用 Doyle 法计算,器官功能障碍使用小儿逻辑器官功能障碍-2 评分评估。大多数患者在 PARDS 发病时表现出超过一个肺外器官功能障碍。随着 PARDS 严重程度的增加,P50 增加(轻度(26.6 [24.9-29.6])、中度(26.8 [25.0-29.5])和重度 PARDS(29.1 [26.1-32.4] mmHg;P=0.025)。此外,P50 与肺外器官功能障碍评分呈显著正相关(β=0.158,P=0.007)和死亡率(调整后的危险比,1.056;95%置信区间,1.015-1.098;P=0.007),与初始 PARDS 严重程度无关。P50 与死亡率之间的关系主要由肺外器官功能障碍介导。PARDS 诊断时 P50 值较高可能通过肺外器官功能障碍与死亡率相关。未来的研究应考虑将 P50 作为 PARDS 患者风险分层的潜在候选指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9a5/9372160/1ade4b0c0b29/41598_2022_18038_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9a5/9372160/e6801387f7d1/41598_2022_18038_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9a5/9372160/1ade4b0c0b29/41598_2022_18038_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9a5/9372160/e6801387f7d1/41598_2022_18038_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9a5/9372160/1ade4b0c0b29/41598_2022_18038_Fig2_HTML.jpg

相似文献

1
P50 implies adverse clinical outcomes in pediatric acute respiratory distress syndrome by reflecting extrapulmonary organ dysfunction.P50 通过反映肺外器官功能障碍暗示了儿科急性呼吸窘迫综合征的不良临床结局。
Sci Rep. 2022 Aug 11;12(1):13666. doi: 10.1038/s41598-022-18038-6.
2
Risk Stratification in Pediatric Acute Respiratory Distress Syndrome: A Multicenter Observational Study.儿科急性呼吸窘迫综合征的风险分层:一项多中心观察性研究。
Crit Care Med. 2017 Nov;45(11):1820-1828. doi: 10.1097/CCM.0000000000002623.
3
Pediatric Acute Respiratory Distress Syndrome Severity and Health-Related Quality of Life Outcomes: Single-Center Retrospective Cohort, 2011-2017.儿科急性呼吸窘迫综合征严重程度与健康相关生活质量结局:2011-2017 年单中心回顾性队列研究。
Pediatr Crit Care Med. 2024 Sep 1;25(9):816-827. doi: 10.1097/PCC.0000000000003552. Epub 2024 Jun 4.
4
Noninvasive Ventilation for Pediatric Acute Respiratory Distress Syndrome: Experience From the 2016/2017 Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology Prospective Cohort Study.儿科急性呼吸窘迫综合征的无创通气:2016/2017 年儿科急性呼吸窘迫综合征发病率和流行病学前瞻性队列研究的经验。
Pediatr Crit Care Med. 2023 Sep 1;24(9):715-726. doi: 10.1097/PCC.0000000000003281. Epub 2023 May 31.
5
Immunocompromised-Associated Pediatric Acute Respiratory Distress Syndrome: Experience From the 2016/2017 Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology Prospective Cohort Study.免疫低下相关儿童急性呼吸窘迫综合征:来自 2016/2017 年儿童急性呼吸窘迫综合征发生率和流行病学前瞻性队列研究的经验。
Pediatr Crit Care Med. 2024 Apr 1;25(4):288-300. doi: 10.1097/PCC.0000000000003421. Epub 2024 Jan 18.
6
Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study.儿科急性呼吸窘迫综合征的发病率和流行病学(PARDIE):一项国际性、观察性研究。
Lancet Respir Med. 2019 Feb;7(2):115-128. doi: 10.1016/S2213-2600(18)30344-8. Epub 2018 Oct 22.
7
Association of Interventions With Outcomes in Children At-Risk for Pediatric Acute Respiratory Distress Syndrome: A Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology Study.儿童发生小儿急性呼吸窘迫综合征风险的干预措施与结局的关联:一项小儿急性呼吸窘迫综合征发病率和流行病学研究。
Pediatr Crit Care Med. 2023 Jul 1;24(7):574-583. doi: 10.1097/PCC.0000000000003217. Epub 2023 Feb 21.
8
Non-Invasive Ventilation in Children with Paediatric Acute Respiratory Distress Syndrome.儿童急性呼吸窘迫综合征的无创通气。
Ann Acad Med Singap. 2019 Jul;48(7):224-232.
9
Diagnostic, Management, and Research Considerations for Pediatric Acute Respiratory Distress Syndrome in Resource-Limited Settings: From the Second Pediatric Acute Lung Injury Consensus Conference.资源有限环境下儿科急性呼吸窘迫综合征的诊断、管理和研究考虑:来自第二届儿科急性肺损伤共识会议。
Pediatr Crit Care Med. 2023 Feb 1;24(12 Suppl 2):S148-S159. doi: 10.1097/PCC.0000000000003166. Epub 2023 Jan 20.
10
Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome.儿科急性呼吸窘迫综合征神经肌肉阻滞研究(PAN 研究):一项中度至重度儿科急性呼吸窘迫综合征早期神经肌肉阻滞的 IV 期随机对照试验。
Trials. 2022 Jan 31;23(1):96. doi: 10.1186/s13063-021-05927-w.

引用本文的文献

1
Changes of Dissociative Properties of Hemoglobin in Patients with Chronic Kidney Disease.慢性肾脏病患者血红蛋白解离特性的变化
Diagnostics (Basel). 2024 Jun 8;14(12):1219. doi: 10.3390/diagnostics14121219.

本文引用的文献

1
Definition and global epidemiology of pediatric acute respiratory distress syndrome.儿童急性呼吸窘迫综合征的定义与全球流行病学
Ann Transl Med. 2019 Oct;7(19):502. doi: 10.21037/atm.2019.09.31.
2
Characteristics of Nonpulmonary Organ Dysfunction at Onset of ARDS Based on the Berlin Definition.基于柏林定义的 ARDS 发病时非肺部器官功能障碍的特征。
Respir Care. 2019 May;64(5):493-501. doi: 10.4187/respcare.06165. Epub 2019 Apr 16.
3
Biomarkers for Acute Respiratory Distress syndrome and prospects for personalised medicine.急性呼吸窘迫综合征的生物标志物与个性化医疗前景
J Inflamm (Lond). 2019 Jan 15;16:1. doi: 10.1186/s12950-018-0202-y. eCollection 2019.
4
Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study.儿科急性呼吸窘迫综合征的发病率和流行病学(PARDIE):一项国际性、观察性研究。
Lancet Respir Med. 2019 Feb;7(2):115-128. doi: 10.1016/S2213-2600(18)30344-8. Epub 2018 Oct 22.
5
Epidemiology of Cause of Death in Pediatric Acute Respiratory Distress Syndrome.儿科急性呼吸窘迫综合征死亡原因的流行病学。
Crit Care Med. 2018 Nov;46(11):1811-1819. doi: 10.1097/CCM.0000000000003371.
6
Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征
N Engl J Med. 2017 Aug 10;377(6):562-572. doi: 10.1056/NEJMra1608077.
7
Pediatric ARDS.小儿急性呼吸窘迫综合征
Respir Care. 2017 Jun;62(6):718-731. doi: 10.4187/respcare.05591.
8
Mortality in Pediatric Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.儿科急性呼吸窘迫综合征的死亡率:系统评价和荟萃分析。
J Intensive Care Med. 2019 Jul;34(7):563-571. doi: 10.1177/0885066617705109. Epub 2017 May 1.
9
Should modulation of p50 be a therapeutic target in the critically ill?p50的调节是否应成为重症患者的治疗靶点?
Expert Rev Hematol. 2017 May;10(5):449-458. doi: 10.1080/17474086.2017.1313699. Epub 2017 Apr 12.
10
Epidemiology and Outcomes of Pediatric Multiple Organ Dysfunction Syndrome.儿童多器官功能障碍综合征的流行病学及转归
Pediatr Crit Care Med. 2017 Mar;18(3_suppl Suppl 1):S4-S16. doi: 10.1097/PCC.0000000000001047.